Bu-ga syndrome is a general term for a group of diseases in which the hepatic veins and, or post-hepatic inferior vena cava are obstructed, and the disease is relatively rare, but has a high incidence in Henan and Shandong. The etiology of the disease is currently unknown, and patients abroad are most often seen with a combination of multiple coagulation abnormalities. Morphologically, Bu-plus syndrome can be divided into hepatic vein type, inferior vena cava type and mixed type, and mixed type Bu-plus syndrome is predominant in China. The treatment of Bu-plus syndrome is arduous and complicated, especially the mixed type Bu-plus syndrome. In the 1970s and 1980s, treatment was mainly based on bypass and diversion surgery, and it was proposed that Boo-ga syndrome should be treated surgically as soon as it was diagnosed, but such surgery was risky, traumatic and costly. At the beginning of the 21st century, minimally invasive interventional treatment for Bu-ga syndrome was recognized by most scholars. This treatment is relatively low-risk, less invasive, less expensive, effective, and reproducible, and soon received good reviews from patients. However, interventional treatment has certain limitations in the treatment process, and the mixed type of Bu-plus syndrome often cannot completely open the hepatic vein by interventional treatment, thus laying the hidden danger of continued liver function damage until liver failure. Therefore, the author believes that the treatment of Bu-plus syndrome should not be blindly based on interventional therapy. Many patients have different degrees of liver function impairment and symptoms of portal hypertension at the beginning of treatment, and the optimal treatment plan is to choose the appropriate individual treatment plan according to the patient’s condition. Li Lin, Department of Hepatobiliary-Pancreatic and Liver Transplantation, First Affiliated Hospital of Zhengzhou University